Neutrophil cell death, activation and bacterial infection in cystic fibrosis.
about
The Role of Serine Proteases and Antiproteases in the Cystic Fibrosis LungHigh mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserineAlpha-1 antitrypsin supplementation improves alveolar macrophages efferocytosis and phagocytosis following cigarette smoke exposure.High-Dose Ibuprofen in Cystic Fibrosis.CFTR inhibition provokes an inflammatory response associated with an imbalance of the annexin A1 pathway.Isolation and characterization of microparticles in sputum from cystic fibrosis patientsUltrafine and nanoparticles-induced oxidative stress: the role of heme oxygenase-1 and carbon monoxide as anti-inflammatory pathways.Inactivation of the rhlA gene in Pseudomonas aeruginosa prevents rhamnolipid production, disabling the protection against polymorphonuclear leukocytes.Neutrophil necrosis and annexin 1 degradation associated with airway inflammation in lung transplant recipients with cystic fibrosisExpression of Pseudomonas aeruginosa toxin ExoS effectively induces apoptosis in host cells.Regulation of phagocyte lifespan in the lung during bacterial infection.Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways.The Burkholderia cenocepacia OmpA-like protein BCAL2958: identification, characterization, and detection of anti-BCAL2958 antibodies in serum from B. cepacia complex-infected Cystic Fibrosis patients.Galectin-9 signaling through TIM-3 is involved in neutrophil-mediated Gram-negative bacterial killing: an effect abrogated within the cystic fibrosis lung.End-stage cystic fibrosis lung disease is characterised by a diverse inflammatory pattern: an immunohistochemical analysis.Glutaredoxin-1 attenuates S-glutathionylation of the death receptor fas and decreases resolution of Pseudomonas aeruginosa pneumonia.Interactions between Neutrophils and Pseudomonas aeruginosa in Cystic Fibrosis.Resolution of cell-mediated airways diseases.Secondary necrosis: the natural outcome of the complete apoptotic program.The cystic fibrosis neutrophil: a specialized yet potentially defective cell.Resolution of leucocyte-mediated mucosal diseases. A novel in vivo paradigm for drug developmentThe Role of Human Beta-Defensin-2 in Pseudomonas aeruginosa Pulmonary Infection in Cystic Fibrosis Patients.Proteomics of hosts and pathogens in cystic fibrosis.Considerations for the Conduct of Clinical Trials with Antiinflammatory Agents in Cystic Fibrosis. A Cystic Fibrosis Foundation Workshop Report.Mechanosensitivity of wild-type and G551D cystic fibrosis transmembrane conductance regulator (CFTR) controls regulatory volume decrease in simple epithelia.Whey protein hydrolysates decrease IL-8 secretion in lipopolysaccharide (LPS)-stimulated respiratory epithelial cells by affecting LPS binding to Toll-like receptor 4.Biological monitoring of particulate matter accumulated in the lungs of urban asthmatic children in the Tel-Aviv area.Azithromycin use in patients with cystic fibrosis.Urokinase-type plasminogen activator inhibits efferocytosis of neutrophils.Impairment of apoptotic cell engulfment by pyocyanin, a toxic metabolite of Pseudomonas aeruginosa.(n-3) long-chain PUFA differentially affect resistance to Pseudomonas aeruginosa infection of male and female cftr-/- mice.Asymmetric dimethylarginine and related metabolites in exhaled breath condensate of children with cystic fibrosis.Host Defence against Bacterial Biofilms: “Mission Impossible”?
P2860
Q26799771-8F011977-CC07-4323-9CCD-83C2C5CAC601Q28118997-5621F2B2-15CA-4C4E-A429-5A9DF9F6D3EAQ33610265-BF14E423-5C46-4612-8CC7-1020A57B85A9Q33678000-584CE53E-E898-4ECF-9F80-E22A2FD82544Q33947206-80364B59-2D59-422E-8D08-668D824C7D7BQ34020055-5C3D790C-6F56-4D69-A3E4-1FEA5FA1C128Q34108560-54958806-03FA-4074-8816-857BF6B62BD5Q34381458-9285DB68-2735-4286-AD30-443E8D5D49D5Q34381896-108FEA9C-6929-4254-9210-AFA909E07A82Q35220416-578DEBD1-D26A-4D95-AF9D-9012565B507AQ36396599-D8B10B0A-FBFF-4B47-927A-012272BC8FABQ36670017-DE6B12D9-95B4-48E1-8A8F-2319733CD3B7Q37026632-72ECB266-DA85-4499-8936-9081CB83B12CQ37203240-5D78AC8F-6743-46CF-9283-97D460F9C59DQ37576557-99780231-CA3A-4B8E-92F8-4062D6A1C701Q37688517-E5601EA3-D5E0-46B1-8994-D5F992850791Q37727995-DAE0521E-52C6-498E-8261-D1E9D93D9A25Q37764375-08CAE478-288D-4531-8281-82836495F149Q37802938-8D076290-491C-41E1-AEA1-6870080D9C39Q37839809-8FE5459C-324B-4087-B9BD-260D3EFB079CQ37952781-27BE2206-15B9-42F2-B893-40E1B8F2C550Q38240975-77EF0890-6715-42F0-AF34-31984748ADA2Q38270707-4575852E-BE25-4192-B89F-D59756E2EB0EQ38543069-3FDD867F-073B-41B9-A9F0-6CA38B39F903Q38810598-6FA6822F-3439-402A-9057-94BD91E4C90DQ39216925-B6054D0F-0498-43B0-9B90-CE9D68696DE6Q40216266-9AA66B40-81F9-4D94-9810-CAAE3B941DCAQ41428470-27BB5425-A481-41B4-B99B-92F91EF0A003Q41973656-B3769A93-77FE-41B2-BD21-B757C4B4DA32Q46966094-9A5B8D5B-38D6-42EA-A1B7-1C6AF8807D1FQ51470852-7E188EB5-AF79-4682-B8CE-E3A154ACA83BQ51519350-3CA02ECB-3C9C-4379-B031-192FBE3EB636Q58692848-25F0A416-21B6-48D5-8F71-2A8688AD055D
P2860
Neutrophil cell death, activation and bacterial infection in cystic fibrosis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Neutrophil cell death, activation and bacterial infection in cystic fibrosis.
@ast
Neutrophil cell death, activation and bacterial infection in cystic fibrosis.
@en
type
label
Neutrophil cell death, activation and bacterial infection in cystic fibrosis.
@ast
Neutrophil cell death, activation and bacterial infection in cystic fibrosis.
@en
prefLabel
Neutrophil cell death, activation and bacterial infection in cystic fibrosis.
@ast
Neutrophil cell death, activation and bacterial infection in cystic fibrosis.
@en
P2093
P2860
P356
P1433
P1476
Neutrophil cell death, activation and bacterial infection in cystic fibrosis
@en
P2093
P2860
P304
P356
10.1136/THX.2004.038240
P407
P577
2005-08-01T00:00:00Z